Adakveo Uses, Dosage, Side Effects and more
| Trade Name | Adakveo |
| Generic | Crizanlizumab+tmca Injection |
| Weight | 10mg/ml, |
| Type | Injection, For Intravenous Use Date Of Approval: November 15, 2019 Company: Novartis Pharmaceuticals Corporation, Intravenous Solution |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | United States, |
| Last Updated: | January 7, 2025 at 1:49 am |
